Open AccessNivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow‐up of 30 Patients Treated Within the CheckMate 205 Trial in a Single‐Center
Author(s) -
Momotow Jesko,
Goergen Helen,
Behringer Karolin,
Bröckelmann Paul J.,
Borchmann Sven,
Tresckow Bastian v.,
Kobe Carsten,
Engert Andreas,
Sasse Stephanie
Publication year - 2019
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/hs9.0000000000000293
Subject(s) - medicine , nivolumab , refractory (planetary science) , oncology , pembrolizumab , population , autologous stem cell transplantation , salvage therapy , transplantation , progressive disease , chemotherapy , surgery , immunotherapy , cancer , physics , environmental health , astrobiology